US Patent 9320739 RAF kinase modulator compounds and methods of use thereof

Patent 9320739 was granted and assigned to Ambit Biosciences on April, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ambit Biosciences

Current Assignee

Ambit Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93207390

Patent Inventor Names

Sunny Abraham0

Qi Chao0

Raffaella Faraoni0

Shripad S. Bhagwat0

Andiliy G. Lai0

Brian T. Campbell0

Eduardo Setti0

Kelly G. Sprankle0

...

Date of Patent

April 26, 2016

Patent Application Number

146058340

Date Filed

January 26, 2015

Patent Primary Examiner

‌

Jeffrey H Murray

Patent abstract

Compositions of 1-(3-((6,7-dimethoxyquinazolin-4-yl)oxy)phenyl)-3-(5-(1,1,1, -trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea are provided for modulating the activity of RAF kinases, including BRAF kinase and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder mediated by RAF kinases.